Literature DB >> 14743973

Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats.

X D Liu1, L Zhang, L Xie.   

Abstract

Effect of P-glycoprotein (P-gp) inhibitors erythromycin (Ery) and cyclosporin A(CsA) on brain pharmacokinetics of nimodipine (NMD) in rats was studied. NMD concentrations in rat plasma and brain were determined after iv 2 mg/kg NMD alone, co-administration with Ery and CsA, respectively. It was found that concentrations of NMD in plasma of the three groups had a little difference, but brain concentrations of NMD in rats co-administrated with Ery and CsA were significantly higher than those in rats NMD alone. Significances of NMD in rat brain were found at 20, 40, 60 and 90 min after iv NMD. The brain T(1/2) in rat treated with ery(75.0 min) and CsA(79.0 min) were larger than that (44.2 min) in rats NMD alone. The results indicated that P-gp inhibitors Ery and CsA may increase concentration in rat brain by inhibiting elimination of NMD from brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14743973     DOI: 10.1007/BF03220184

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain.

Authors:  U Schumacher; K Mollgård
Journal:  Histochem Cell Biol       Date:  1997-08       Impact factor: 4.304

2.  Functional involvement of P-glycoprotein in blood-brain barrier.

Authors:  T Tatsuta; M Naito; T Oh-hara; I Sugawara; T Tsuruo
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

3.  Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats.

Authors:  Q Wang; H Yang; D W Miller; W F Elmquist
Journal:  Biochem Biophys Res Commun       Date:  1995-06-26       Impact factor: 3.575

4.  Cyclosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats.

Authors:  Xiao-Dong Liu; Guo-Yu Pan; Lin Xie; Yuan-Yuan Hou; Wen Lan; Qing Su; Guo-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2002-03       Impact factor: 6.150

5.  Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.

Authors:  L Wang; K Kitaichi; C S Hui; K Takagi; K Takagi; M Sakai; K Yokogawa; K I Miyamoto; T Hasegawa
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-08       Impact factor: 2.557

6.  P glycoprotein regulated transport of glutamate at blood brain barrier.

Authors:  X D Liu; G Q Liu
Journal:  Acta Pharmacol Sin       Date:  2001-02       Impact factor: 6.150

7.  Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice.

Authors:  L F Marques-Santos; R R Bernardo; E F de Paula; V M Rumjanek
Journal:  Pharmacol Toxicol       Date:  1999-03

8.  Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.

Authors:  C S Hughes; S L Vaden; C A Manaugh; G S Price; L C Hudson
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

9.  Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.

Authors:  A Tsuji; I Tamai; A Sakata; Y Tenda; T Terasaki
Journal:  Biochem Pharmacol       Date:  1993-09-14       Impact factor: 5.858

10.  P-glycoprotein restricted transport of nimodipine across blood-brain barrier.

Authors:  Li Zhang; Xiao-Dong Liu; Lin Xie; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2003-09       Impact factor: 6.150

View more
  4 in total

1.  Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort.

Authors:  Ying Zhao; Desheng Zhai; Hui He; Tingting Li; Xijing Chen; Hui Ji
Journal:  Eur J Clin Pharmacol       Date:  2009-02-11       Impact factor: 2.953

2.  Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.

Authors:  Chun Wu; Qiongfeng Liao; Meicun Yao; Xinjun Xu; Yuting Zhou; Xueying Hou; Zhiyong Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-15       Impact factor: 2.441

3.  Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats.

Authors:  X D Liu; X L Wang; L Xie; G J Wang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

Review 4.  Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.

Authors:  Priya Yadav; Suresh V Ambudkar; N Rajendra Prasad
Journal:  J Nanobiotechnology       Date:  2022-09-24       Impact factor: 9.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.